Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gabel

Showing results (271-280 of 308) with videos related to

Pageof 31
Sort By:
Biochemistry|June 25, 2024
Production and Release of Proinflammatory Mediators by the Cockroach Allergen Bla g 1 via a Shared Membrane-Destabilization MechanismAlexander C Y Foo, Matthew L Edin, Wan-Chi Lin, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|August 1, 1995
In vivo pharmacology of L-159,913, a new highly potent and selective nonpeptide angiotensin II receptor antagonistR A Gabel, S D Kivlighn, G J Zingaro, et al.
Journal of Investigational Allergology & Clinical Immunology|February 9, 2026
A Human Monoclonal Antibody Displays Promiscuous Binding to Multiple Type 1 nsLTP AllergensGage O Leighton, Lars C Pedersen, Jungki Min, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonistD L Williams, K L Murphy, N A Nolan, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome InhibitorsDavid Harrison, Mark G Bock, John R Doedens, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X₇ receptorChakrapani Subramanyam, Allen J Duplantier, Mark A Dombroski, et al.
Nucleic Acids Research|April 20, 2023
Changes in metabolic landscapes shape divergent but distinct mutational signatures and cytotoxic consequences of redox stressNatalya P Degtyareva, Victoria C Placentra, Scott A Gabel, et al.
The Journal of Biological Chemistry|March 8, 2003
Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processingRonald E Laliberte, David G Perregaux, Lise R Hoth, et al.
American Journal of Hypertension|January 1, 1995
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996S D Kivlighn, G J Zingaro, R A Gabel, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 2024
Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances PotencyPamela Smolak, MyTrang Nguyen, Christine Diamond, et al.
Pageof 31

Showing results (271-280 of 308) with videos related to

Sort By:
Pageof 31
Biochemistry|June 25, 2024
Production and Release of Proinflammatory Mediators by the Cockroach Allergen Bla g 1 via a Shared Membrane-Destabilization MechanismAlexander C Y Foo, Matthew L Edin, Wan-Chi Lin, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|August 1, 1995
In vivo pharmacology of L-159,913, a new highly potent and selective nonpeptide angiotensin II receptor antagonistR A Gabel, S D Kivlighn, G J Zingaro, et al.
Journal of Investigational Allergology & Clinical Immunology|February 9, 2026
A Human Monoclonal Antibody Displays Promiscuous Binding to Multiple Type 1 nsLTP AllergensGage O Leighton, Lars C Pedersen, Jungki Min, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Pharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonistD L Williams, K L Murphy, N A Nolan, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome InhibitorsDavid Harrison, Mark G Bock, John R Doedens, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X₇ receptorChakrapani Subramanyam, Allen J Duplantier, Mark A Dombroski, et al.
Nucleic Acids Research|April 20, 2023
Changes in metabolic landscapes shape divergent but distinct mutational signatures and cytotoxic consequences of redox stressNatalya P Degtyareva, Victoria C Placentra, Scott A Gabel, et al.
The Journal of Biological Chemistry|March 8, 2003
Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processingRonald E Laliberte, David G Perregaux, Lise R Hoth, et al.
American Journal of Hypertension|January 1, 1995
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996S D Kivlighn, G J Zingaro, R A Gabel, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 2024
Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances PotencyPamela Smolak, MyTrang Nguyen, Christine Diamond, et al.
Pageof 31